Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Mark Hurwitz MD
Open to Accrual
To assess the benefit of docetaxel as measured by improvement in freedom from progression (phase II) and subsequently metastasis free survival (phase III) when given in combination with radiation and androgen deprivation in treatment of high risk prostate cancer post-radical prostatectomy
Pathologically proven diagnosis of adenocarcinoma of the prostate as confirmed at time of prostatectomy. Post prostatectomy Gleason ≥ 7, baseline PSA nadir ≥ 0.2 ng/ml. Surgical FFPE specimen must be submitted to GenomeDx for genomic analysis on DECIPHER GRID platform per Section 10 of the protocol.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.